Several ,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines were synthe
sized and primarily evaluated for antitumor activity against the murin
e L1210 leukemia. All of the compounds tested were capable of producin
g ''cures'' of mice bearing this tumor. One of the most active agents
of this class, thyl)-2-[[(2-chlorothyl)-amino]carbonyl]hydrazine, was
further evaluated against a spectrum of transplanted murine and human
solid tumors. Pronounced activity was found against all of the tumors
including the murine B16F10 melanoma, M109 lung carcinoma, M5076 retic
ulum cell sarcoma, and the human LX-1 lung carcinoma. The activities o
bserved compared favorably with those of the established antitumor dru
gs, cyclophosphamide, mitomycin C, and the nitrosoureas, evaluated con
comitantly.